Can biomarkers balance stroke and bleeding risk?

Affiliations

¹ Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK; Department of Cardiovascular Medicine, University Hospital Muenster, Germany; Atrial Fibrillation NETwork, Muenster, Germany; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK. Electronic address: p.kirchhof@bham.ac.uk.
² Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK; Department of Cardiovascular Medicine, University Hospital Muenster, Germany; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Comment

Paulus Kirchhof et al. Lancet. 2016.

. 2016 Jun 4;387(10035):2266-2268.

doi: 10.1016/S0140-6736(16)30121-0. Epub 2016 Apr 4.

¹ Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK; Department of Cardiovascular Medicine, University Hospital Muenster, Germany; Atrial Fibrillation NETwork, Muenster, Germany; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK. Electronic address: p.kirchhof@bham.ac.uk.
² Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK; Department of Cardiovascular Medicine, University Hospital Muenster, Germany; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

No abstract available

Comment on

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.
Hijazi Z, Oldgren J, Lindbäck J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Held C, Hylek EM, Lopes RD, Siegbahn A, Yusuf S, Granger CB, Wallentin L; ARISTOTLE and RE-LY Investigators. Hijazi Z, et al. Lancet. 2016 Jun 4;387(10035):2302-2311. doi: 10.1016/S0140-6736(16)00741-8. Epub 2016 Apr 4. Lancet. 2016. PMID: 27056738 Clinical Trial.